Versigent PLC

Securities Trading Plans of Executive Officers and Directors

During the three months ended September 30, 2026, none of the individuals serving as the Company’s directors or “officers,” as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended, at that time adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

Indemnification Agreements

As of November 3, 2026, the Company entered into indemnification agreements with each director and each “officer,” as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended, to indemnify them for any liabilities they may incur due to their service for the Company, including any service provided to any subsidiary or affiliate of the Company (other than any Aptiv entities that are not currently affiliates of the Company) to the maximum extent permitted by law, including advancement of legal expenses, but excluding claims related to short-swing profits, clawbacks required by securities laws or as otherwise prohibited under applicable law or the jurisdiction of incorporation of the Company or the applicable affiliated entity. The agreement also obligates the Company us to use all reasonable endeavors to obtain customary insurance for such claims.

Shareholder Proposals

The Company’s Board has established April 27, 2027 as the date of the Company’s 2027 Annual General Meeting of Shareholders. Information regarding the 2027 Annual General Meeting will be disclosed in the Company’s definitive proxy statement for the 2027 Annual General Meeting to be filed with the Securities and Exchange Commission (the “Proxy Statement”).

The Company became a public company on April 1, 2026 and did not hold an annual meeting of shareholders since becoming a public company. Under Rule 14a-8(e) of the Securities Exchange Act of 1934, as amended (“Rule 14a-8”), the Company may establish a deadline for any shareholder seeking to submit a proposal to be included in the Proxy Statement under Rule 14a-8 at a reasonable time before the Company begins to publish its proxy materials. The Company has established November 18, 2026 as the deadline, and any such proposal must be received at the Company’s principal executive offices no later than the close of business on such date and comply with the procedures and requirements of Rule 14a-8.

Shareholders seeking to bring a matter before a general meeting outside the process described above may do so by following the procedures set forth in our Memorandum and Articles of Association and the Companies (Jersey) Law 1991, as amended.

Shareholders proposing nominees for election to the Board at 2027 Annual General Meeting must give timely written notice received at the Company’s principal executive offices no later than the close of business on March 8, 2027, and no earlier than November 28, 2026. In addition to complying with the Company’s Memorandum and Articles of Association, to nominate directors, shareholders must give timely notice that complies with the additional requirements of Rule 14a-19 of the Securities Exchange Act of 1934, as amended, and which must be received no later than January 29, 2027.